Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 1 of 1 (100%) have an AI response strategy ready
Gelmedix Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. The concentration of the current workload into a single pending action suggests a focused patent strategy for the company's medical developments. Practitioners can prioritize the specific procedural rules of this 1 distinct art unit to optimize their prosecution strategy.
The busiest examiner for the company is JANOSKO, CHASITY PAIGE, who is responsible for 1 pending office action. This examiner handles the entire pending workload for the company, as the total pending office actions count is 1. With 1 distinct examiner involved, the prosecution process is centralized. Practitioners should focus on the specific examination style of JANOSKO, CHASITY PAIGE within the Biotechnology & Pharmaceuticals area to navigate this pending matter successfully. Since no other examiners are currently reviewing the company's filings, the outcome of this matter depends entirely on the interaction with this 1 distinct examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18248044 | GELMA POLYMER COMPOSITIONS AND USES THEREOF | JANOSKO, CHASITY PAIGE | 63d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18248044 | GELMA POLYMER COMPOSITIONS AND USES THEREOF | JANOSKO, CHASITY PAIGE | 63d |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18248044 | GELMA POLYMER COMPOSITIONS AND USES THEREOF | JANOSKO, CHASITY PAIGE | 1613 | §103§112 | Final Rejection | 63d | AI Ready | Apr 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial